- 14 Mar 2002
- 21,050
- 18,903
Acute hemolytic streptococcal bacterial infections, characterized by their rapid progression and 30-70% fatality rate, are spreading in Japan at an accelerated pace compared to 2023—a year that already witnessed a record number of cases. Within the first two months of 2024, the patient count reached 40% of last year's total. While the exact reasons behind this surge remain unclear, the health ministry is intensifying monitoring efforts by studying strains known for their pathogenicity and infectiousness.
mainichi.jp
www.otsuka.co.jp
According to provisional figures from the National Institute of Infectious Diseases, there were 941 hemolytic streptococcus cases reported nationwide last year. The number of patients has continued to increase this year, reaching 378 as of Feb. 25. Cases have been confirmed in 45 of Japan's 47 prefectures, with only Akita and Iwate recording zero. Group A hemolytic streptococcus, which causes sore throats mainly in children, is a representative example among several pathogenic bacteria. Although infections often present similar symptoms to a cold, in rare cases and regardless of age, they can escalate to severe conditions including strep throat, tonsillitis, pneumonia and meningitis. Once the infection becomes acute, it can cause multiple organ failure and necrosis in tissue surrounding the muscles. According to the health ministry, it is unknown how infections escalate. However, the prevalence of sore throats among children since last summer is cited as a contributing factor in the increase in severe cases. Additionally, strains within Group A streptococcus known for their high pathogenicity, already widely reported in Britain, have also been confirmed domestically. In January, the ministry asked local governments to analyze strains collected from acute cases.
Dangerous strep bacterial infections on pace to hit new record high in Japan - The Mainichi
TOKYO -- Rapidly progressing and known for their 30-70% fatality rate, acute hemolytic streptococcal bacterial infections are spreading in Japan at a
Group A hemolytic streptococcus: pathogen and clinical presentation | Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical's Health and Illness: Group A hemolytic streptococcus: pathogen and clinical presentation